Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip

被引:130
作者
Kwak, Bongseop [1 ]
Ozcelikkale, Altug [1 ]
Shin, Crystal S. [2 ]
Park, Kinam [2 ,3 ]
Han, Bumsoo [1 ,3 ,4 ]
机构
[1] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
[3] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA
[4] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA
关键词
Cancer; Tumor microenvironment; Microfluidics; Nanoparticle transport; TARGETED DRUG-DELIVERY; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CANCER; MODELS; SIZE; CULTURE; CELLS; NANOTECHNOLOGY; NANOMEDICINE;
D O I
10.1016/j.jconrel.2014.08.027
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Delivery of therapeutic agents selectively to tumor tissue, which is referred as "targeted delivery," is one of the most ardently pursued goals of cancer therapy. Recent advances in nanotechnology enable numerous types of nanoparticles (NPs) whose properties can be designed for targeted delivery to tumors. In spite of promising early results, the delivery and therapeutic efficacy of the majority of NPs are still quite limited. This is mainly attributed to the limitation of currently available tumor models to test these NPs and systematically study the effects of complex transport and pathophysiological barriers around the tumors. In this study, thus, we developed a new in vitro tumor model to recapitulate the tumor microenvironment determining the transport around tumors. This model, named tumor-microenvironment-on-chip (T-MOC), consists of 3-dimensional microfluidic channels where tumor cells and endothelial cells are cultured within extracellular matrix under perfusion of interstitial fluid. Using this T-MOC platform, the transport of NPs and its variation due to tumor microenvironmental parameters have been studied including cut-off pore size, interstitial fluid pressure, and tumor tissue microstructure. The results suggest that T-MOC is capable of simulating the complex transport around the tumor, and providing detailed information about NP transport behavior. This finding confirms that NPs should be designed considering their dynamic interactions with tumor microenvironment. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:157 / 167
页数:11
相关论文
共 42 条
[1]   Tumour-on-a-chip provides an optical window into nanoparticle tissue transport [J].
Albanese, Alexandre ;
Lam, Alan K. ;
Sykes, Edward A. ;
Rocheleau, Jonathan V. ;
Chan, Warren C. W. .
NATURE COMMUNICATIONS, 2013, 4
[2]  
BAE Y.H. E., 2013, Cancer Targeted Drug Delivery An Elusive Dream
[3]   Targeted drug delivery to tumors: Myths, reality and possibility [J].
Bae, You Han ;
Park, Kinam .
JOURNAL OF CONTROLLED RELEASE, 2011, 153 (03) :198-205
[4]   Genetically engineered models have advantages over xenografts for preclinical studies [J].
Becher, OJ ;
Holland, EC .
CANCER RESEARCH, 2006, 66 (07) :3355-3358
[5]   Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation [J].
Brown, E ;
McKee, T ;
diTomaso, E ;
Pluen, A ;
Seed, B ;
Boucher, Y ;
Jain, RK .
NATURE MEDICINE, 2003, 9 (06) :796-800
[6]  
Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
[7]   Monolayer and Spheroid Culture of Human Liver Hepatocellular Carcinoma Cell Line Cells Demonstrate Distinct Global Gene Expression Patterns and Functional Phenotypes [J].
Chang, Tammy T. ;
Hughes-Fulford, Millie .
TISSUE ENGINEERING PART A, 2009, 15 (03) :559-567
[8]   Nanoparticle Characterization: State of the Art, Challenges, and Emerging Technologies [J].
Cho, Eun Jung ;
Holback, Hillary ;
Liu, Karen C. ;
Abouelmagd, Sara A. ;
Park, Joonyoung ;
Yeo, Yoon .
MOLECULAR PHARMACEUTICS, 2013, 10 (06) :2093-2110
[9]   Fluorescence-Tagged Gold Nanoparticles for Rapidly Characterizing the Size-Dependent Biodistribution in Tumor Models [J].
Chou, Leo Y. T. ;
Chan, Warren C. W. .
ADVANCED HEALTHCARE MATERIALS, 2012, 1 (06) :714-721
[10]   Contemporary pre-clinical development of anticancer agents - What are the optimal preclinical models? [J].
Damia, Giovanna ;
D'Incalci, Maurizio .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (16) :2768-2781